SCHEMBL10065301

SCHEMBL10065301

c1ccc(-c2ccc3c(c2)c2cc(-c4nc5ccccc5o4)ccc2n3-c2ccccc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 7/20 0.51
▸ ALDH1A1 P00352 7/20 0.51
▸ KDM4E B2RXH2 7/20 0.51
▸ HPGD P15428 6/20 0.51
▸ HSD17B10 Q99714 5/20 0.51
▸ TP53 P04637 5/20 0.51
▸ KMT2A Q03164 4/20 0.51
▸ MEN1 O00255 3/20 0.51
▸ PKM P14618 1/20 0.51
▸ NPC1 O15118 8/20 0.49
▸ RAB9A P51151 6/20 0.49
▸ HCRTR1 O43613 2/20 0.49
▸ MAPT P10636 2/20 0.49
▸ USP2 O75604 1/20 0.49
▸ TSHR P16473 1/20 0.49
▸ MAPK1 P28482 1/20 0.49
▸ CASP3 P42574 1/20 0.49
▸ NPSR1 Q6W5P4 1/20 0.49
▸ SENP8 Q96LD8 1/20 0.49
▸ SENP7 Q9BQF6 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10065302 1.00 SMN1; SMN2 (0.51) SMN1; SMN2ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL10065303 0.97 KDM4E (0.52) SMN1; SMN2ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL23108471 0.97 NPC1 (0.49) SMN1; SMN2ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL10065402 0.97 NPC1 (0.50) SMN1; SMN2ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL308483 0.97 NPC1 (0.50) SMN1; SMN2ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL23108757 0.97 NPC1 (0.49) SMN1; SMN2ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL10065322 0.97 NPC1 (0.50) SMN1; SMN2ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL10065319 0.97 NPC1 (0.50) SMN1; SMN2ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL22746736 0.96 NPC1 (0.50) SMN1; SMN2ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL22746699 0.96 NPC1 (0.50) SMN1; SMN2ALDH1A1KDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8735597-B2 Benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using benzoxazole derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-05-27 — — US disclosed
US-8735597-B2 Benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using benzoxazole derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-05-27 — — US disclosed
US-20120104376-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-05-03 — — US disclosed
US-20120104376-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-05-03 — — US disclosed
US-8093399-B2 Benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using benzoxazole derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-01-10 — — US disclosed
US-8093399-B2 Benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using benzoxazole derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-01-10 — — US disclosed
US-20100060154-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2010-03-11 — — US disclosed
US-20100060154-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2010-03-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100060154-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative GABRA1, GABRA4, GABRA5 SMN1; SMN2 3845/4885ALDH1A1 165/4885KDM4E 3212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback